Temporin-SHe

General Information


DRACP ID  DRACP01019

Peptide Name   Temporin-SHe

Sequence  FLPALAGIAGLLGKIF

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Pelophylax saharicus

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
THP-1 Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia 45% Killing=12.5µM; 96% Killing=25µM MTT assay 72h 1

Hemolytic Activity  Human erythrocytes: 22% Hemolysis=12.5µM; 84% Hemolysis=25µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01019

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C80H129N17O17

Absent amino acids  CDEHMNQRSTVWY

Common amino acids  L

Mass  186877

Pl  9.7

Basic residues  1

Acidic residues  0

Hydrophobic residues  11

Net charge  1

Boman Index  3818

Hydrophobicity  178.13

Aliphatic Index  165

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32933215

Title  Functional Characterization of Temporin-SHe, a New Broad-Spectrum Antibacterial and Leishmanicidal Temporin-SH Paralog from the Sahara Frog ( Pelophylax saharicus)

Doi 10.3390/ijms21186713

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.